US Stock MarketDetailed Quotes

TRAW Traws Pharma

Watchlist
  • 0.430
  • 0.000-0.02%
Close Jul 29 16:00 ET
  • 0.431
  • +0.001+0.23%
Post 17:21 ET
10.88MMarket Cap-499P/E (TTM)

Traws Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0.00%56K
0.00%226K
0.00%56K
0.00%57K
0.00%57K
0.00%56K
0.00%226K
0.00%56K
0.00%57K
0.00%57K
Operating revenue
0.00%56K
0.00%226K
0.00%56K
0.00%57K
0.00%57K
0.00%56K
0.00%226K
0.00%56K
0.00%57K
0.00%57K
Cost of revenue
Gross profit
Operating expense
-14.94%5.27M
3.38%20.52M
-21.97%4.52M
-9.69%5.15M
11.73%4.67M
47.87%6.19M
18.72%19.85M
51.61%5.79M
40.80%5.7M
-11.17%4.18M
Selling and administrative expenses
58.83%3.36M
7.66%9.09M
3.32%2.08M
27.60%2.69M
3.37%2.21M
-3.34%2.11M
-10.38%8.45M
-2.75%2.02M
-7.84%2.11M
-24.95%2.14M
-General and administrative expense
58.83%3.36M
7.66%9.09M
3.32%2.08M
27.60%2.69M
3.37%2.21M
-3.34%2.11M
-10.38%8.45M
-2.75%2.02M
-7.84%2.11M
-24.95%2.14M
Research and development costs
-53.14%1.91M
0.21%11.43M
-35.49%2.43M
-31.53%2.46M
20.51%2.46M
103.80%4.08M
56.31%11.41M
116.22%3.77M
103.80%3.59M
10.04%2.04M
Operating profit
15.07%-5.21M
-3.42%-20.3M
22.18%-4.46M
9.79%-5.09M
-11.89%-4.61M
-48.52%-6.14M
-18.98%-19.63M
-52.38%-5.73M
-41.38%-5.64M
11.30%-4.12M
Net non-operating interest income expense
Other net income (expense)
-36.74%229K
103.62%1.35M
-11.46%278K
44.03%350K
275.00%360K
3,520.00%362K
99.10%663K
31,500.00%314K
-54.75%243K
-76.81%96K
Other non- operating income (expenses)
-36.74%229K
103.62%1.35M
-11.46%278K
44.03%350K
275.00%360K
3,520.00%362K
5,425.00%663K
31,500.00%314K
3,371.43%243K
838.46%96K
Income before tax
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
-56.33%-5.4M
4.89%-4.02M
Income tax
Net income
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
-56.33%-5.4M
4.89%-4.02M
Net income continuous Operations
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
-56.33%-5.4M
4.89%-4.02M
Minority interest income
Net income attributable to the parent company
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
-56.33%-5.4M
4.89%-4.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
-56.33%-5.4M
4.89%-4.02M
Basic earnings per share
14.29%-0.24
1.10%-0.9
23.08%-0.2
11.54%-0.23
-5.26%-0.2
-40.00%-0.28
5.21%-0.91
-62.50%-0.26
-18.18%-0.26
29.63%-0.19
Diluted earnings per share
14.29%-0.24
1.10%-0.9
23.08%-0.2
11.54%-0.23
-5.26%-0.2
-40.00%-0.28
5.21%-0.91
-62.50%-0.26
-18.18%-0.26
29.63%-0.19
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0.00%56K0.00%226K0.00%56K0.00%57K0.00%57K0.00%56K0.00%226K0.00%56K0.00%57K0.00%57K
Operating revenue 0.00%56K0.00%226K0.00%56K0.00%57K0.00%57K0.00%56K0.00%226K0.00%56K0.00%57K0.00%57K
Cost of revenue
Gross profit
Operating expense -14.94%5.27M3.38%20.52M-21.97%4.52M-9.69%5.15M11.73%4.67M47.87%6.19M18.72%19.85M51.61%5.79M40.80%5.7M-11.17%4.18M
Selling and administrative expenses 58.83%3.36M7.66%9.09M3.32%2.08M27.60%2.69M3.37%2.21M-3.34%2.11M-10.38%8.45M-2.75%2.02M-7.84%2.11M-24.95%2.14M
-General and administrative expense 58.83%3.36M7.66%9.09M3.32%2.08M27.60%2.69M3.37%2.21M-3.34%2.11M-10.38%8.45M-2.75%2.02M-7.84%2.11M-24.95%2.14M
Research and development costs -53.14%1.91M0.21%11.43M-35.49%2.43M-31.53%2.46M20.51%2.46M103.80%4.08M56.31%11.41M116.22%3.77M103.80%3.59M10.04%2.04M
Operating profit 15.07%-5.21M-3.42%-20.3M22.18%-4.46M9.79%-5.09M-11.89%-4.61M-48.52%-6.14M-18.98%-19.63M-52.38%-5.73M-41.38%-5.64M11.30%-4.12M
Net non-operating interest income expense
Other net income (expense) -36.74%229K103.62%1.35M-11.46%278K44.03%350K275.00%360K3,520.00%362K99.10%663K31,500.00%314K-54.75%243K-76.81%96K
Other non- operating income (expenses) -36.74%229K103.62%1.35M-11.46%278K44.03%350K275.00%360K3,520.00%362K5,425.00%663K31,500.00%314K3,371.43%243K838.46%96K
Income before tax 13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M-56.33%-5.4M4.89%-4.02M
Income tax
Net income 13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M-56.33%-5.4M4.89%-4.02M
Net income continuous Operations 13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M-56.33%-5.4M4.89%-4.02M
Minority interest income
Net income attributable to the parent company 13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M-56.33%-5.4M4.89%-4.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M-56.33%-5.4M4.89%-4.02M
Basic earnings per share 14.29%-0.241.10%-0.923.08%-0.211.54%-0.23-5.26%-0.2-40.00%-0.285.21%-0.91-62.50%-0.26-18.18%-0.2629.63%-0.19
Diluted earnings per share 14.29%-0.241.10%-0.923.08%-0.211.54%-0.23-5.26%-0.2-40.00%-0.285.21%-0.91-62.50%-0.26-18.18%-0.2629.63%-0.19
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg